Business
COVID-19 vaccine from Johnson & Johnson may be gamechanger – NEWS.com.au
COVID-19 vaccine from Johnson & Johnson may be gamechanger
As the a global COVID-19 vaccine standoff continues, theres a new player in town and this jabs unique quality could be a gamechanger for the rollout.Johnson & Johnson’s product has an overall efficacy of at least 66 per cent, the company announced on Friday, and crucially, the vaccine only requires one dose.
This sets it apart from the other jabs that have been approved in western countries so far from Pfizer/BioNTech, Moderna and Oxford/AstraZeneca. These vaccines all require two shots, given several…
-
Business17 hours agoIs this the best ASX ETF to diversify your portfolio with?
-
General12 hours agoLiberals go back to basics after crawling to year’s end
-
Business17 hours ago3 of the best ASX ETFs to build significant wealth
-
General17 hours agoTrolls stole Dr Juliet Turner’s joy and in doing so took their own